Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement: Feasibility in clinical practice

Autores da FMUP
Participantes de fora da FMUP
- Silva, G
- Silva, M
- Guerreiro, C
- Pires-Morais, G
- Santos, L
- Melica, B
- Rodrigues, A
- Braga, P
Unidades de investigação
Abstract
Introduction and Objective: Coronary artery disease is highly prevalent among patients with severe aortic stenosis who undergo transcatheter aortic valve replacement (TAVR). As indications for TAVR are now expanding to younger and lower-risk patients, the need for coronary angiography (CA) and percutaneous coronary intervention (PCI) during their lifetime is expected to increase. The objective of our study was to assess the need for CA and the feasibility of re-engaging the coronary ostia after TAVR.Methods: We performed a retrospective analysis of 853 consecutive patients undergoing TAVR between August 2007 and December 2020. Patients who needed CA after TAVR were selected. The primary endpoint was the rate of successful coronary ostia cannulation after TAVR.Results: Of a total of 31 CAs in 28 patients (3.5% of 810 patients analyzed: 57% male, age 77.8 & PLUSMN;7.0 years) performed after TAVR, 28 (90%) met the primary endpoint and in three cannulation was semi-selective. All failed selective coronary ostia cannulations occurred in patients with a self-expanding valve. Sixteen (52%) also had indication for PCI, which was successfully performed in all. The main indication for CA was non-ST-elevation acute coronary syndrome (35%, n=11). Two cases of primary PCI occurred without delay. There were no complications reported during or after the procedure.Conclusion: Although CA was rarely needed in patients after TAVR, selective diagnostic CA was possible in the overwhelming majority of patients. PCI was performed successfully in all cases, without complications.& COPY; 2023 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espan & SIM;a, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).
Dados da publicação
- ISSN/ISSNe:
- 0870-2551, 2174-2030
- Tipo:
- Article
- Páginas:
- 749-756
- Link para outro recurso:
- www.scopus.com
Revista Portuguesa de Cardiologia Sociedade Portuguesa De Cardiologia
Citações Recebidas na Web of Science: 1
Citações Recebidas na Scopus: 1
Documentos
- Não há documentos
Filiações
Keywords
- Aortic valve disease; Coronary angiography; Coronary artery disease; Percutaneous coronary intervention; Transcatheter aortic valve replacement
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies (F-CHECK) - NCT05409846
Investigador Principal: Elisabete Lousada Martins Oliveira Bernardes
Estudo Observacional Académico (F-CHECK) . Sanofi . 2022
The Impact of Obesity on Cardiac Function and Morphology in Aortic Stenosis
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico (Obesity) . 2020
Suboptimal control of cardiovascular risk factors in myocardial infarction survivors
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico (myocard) . 2020
Impacto dos acessos femorais guiados por ecografia vs fluoroscopia nas complicações vasculares associadas à implantação de válvula aórtica percutânea
Investigador Principal: Francisco Pedro Morais Dias de Almeida Sampaio
Estudo Clínico Académico . 2021
Modeling Aortic Stenosis progression: impact on follow-up, treatment, and survival
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico . 2022
Epicardial adipose tissue volume is not an independent predictor of atrial fibrillation recurrence after ablation
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico . 2022
Flow-status in severe aortic stenosis for percutaneous valve implantation: Should we follow the flow?
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico . 2022
Cardiovascular Impact of Metabolic Syndrome: From Mechanisms to New Treatment Targets
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico . 2021
Citar a publicação
Silva G,Silva M,Guerreiro C,Sampaio F,Pires G,Santos L,Melica B,Rodrigues A,Braga P,Fontes R. Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement: Feasibility in clinical practice. Rev Port Cardiol. 2023. 42. (9):p. 749-756. IF:1,800. (4).